Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 53
Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection
Alexandre Pérez‐González, Edward R. Cachay, Antonio Ocampo, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 1047-1047
Open Access | Times Cited: 51
Risk factors for human papillomavirus infection and disease: A targeted literature summary
Marta del Pino, Alex Vorsters, Elmar A. Joura, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Open Access | Times Cited: 6
Human papillomavirus (HPV) vaccination: a call for action in Italy
Giorgio Bogani, Alessandro Ghelardi, Francesco Sopracordevole, et al.
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 7, pp. 1132-1139
Closed Access | Times Cited: 15
What Are the Current HPV Types Contributing to Cervical High Grade Squamous Intraepithelial Lesion, Adenocarcinoma in Situ, and Early Cervical Cancer?
Lina Salman, L.T. Gien, Danielle Vicus, et al.
Journal of Obstetrics and Gynaecology Canada (2025) Vol. 47, Iss. 3, pp. 102783-102783
Open Access
Recommendations and Guidance for Human Papillomavirus (HPV) Vaccination for Adults in Taiwan
Kuan‐Yin Lin, I-Fan Lin, Ping-Feng Wu, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System
Alexandra Cocores, Peter J. Goadsby, Teshamae Monteith
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 2, pp. 275-282
Closed Access | Times Cited: 11
Understanding the HPV associated cancers: A comprehensive review
Nikita Balhara, Ritu Yadav, Shalu Ranga, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis
Rui Lin, Hui Jin, Xin Fu
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1168-1178
Open Access | Times Cited: 9
Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45.
Ryan Ivancic, Taylor Freeman, Brad de Silva, et al.
The Laryngoscope (2024) Vol. 134, Iss. 7, pp. 3226-3229
Open Access | Times Cited: 3
The Role and Development of Peptide Vaccines in Cervical Cancer Treatment
Minhui Wang, Yanyu Gong, Wenyan Kang, et al.
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 3
Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
Giovanni Barillari, Roberto Bei, Vittorio Manzari, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13543-13543
Open Access | Times Cited: 19
Immunogenicity of 2-Dose HPV Vaccine Series for Postpartum Women
Chailee Moss, Runzhi Wang, Saumya S. Sao, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2352996-e2352996
Open Access | Times Cited: 2
History of Human Papilloma Virus Vaccination with a Focus on Italy
Giovanni Gabutti, Matilde Ogliastro
Women (2024) Vol. 4, Iss. 1, pp. 42-52
Open Access | Times Cited: 2
“I Thought It Was Just For Teenagers”: Knowledge, Attitudes, and Beliefs about HPV Vaccination Among Women Aged 27 to 45
Andrea N. Polonijo, Durga Madhab Mahapatra, Brandon Brown
Women s Health Issues (2022) Vol. 32, Iss. 3, pp. 301-308
Open Access | Times Cited: 11
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study
Huakun Lv, Shenyu Wang, Zhenzhen Liang, et al.
Vaccine (2022) Vol. 40, Iss. 23, pp. 3263-3271
Closed Access | Times Cited: 10
Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types
Katrina M. Nolan, Brent L. Seaton, Joseph M. Antonello, et al.
mSphere (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 5
Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study
Yu Liu, Zhiqiang Li, Yuan Li, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 7, pp. 989-995
Open Access | Times Cited: 5
A systematic review on the molecular and clinical association between Human Papillomavirus and Human Immunodeficiency Virus co‐infection in Head, Neck and Oral squamous cell carcinoma
Shreya Chakraborty, Kanagavalli Ramasubbu, Manosi Banerjee, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 5
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting
Kimberly Garces, Alexandra Cocores, Peter J. Goadsby, et al.
Current Pain and Headache Reports (2022) Vol. 26, Iss. 12, pp. 895-918
Open Access | Times Cited: 8
Oral HPV infection clearance and acquisition after nonavalent vaccination in men who have sex with men and transgender women: a prospective analysis
Roberto Rossotti, Alice Nava, Chiara Baiguera, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 9, pp. 1847-1854
Closed Access | Times Cited: 1
Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer
Robert Polten, Ivana Kutle, Jens Hachenberg, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 263-263
Open Access | Times Cited: 6
HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study
Rosa De Vincenzo, N. Caporale, Valentina Bertoldo, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 643-643
Open Access | Times Cited: 6
Human papillomavirus vaccine uptake in South Korea
Jin‐Young Choi, Miseon Kim, Byung Su Kwon, et al.
Clinical and Experimental Obstetrics & Gynecology (2022) Vol. 49, Iss. 1
Open Access | Times Cited: 4
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
Hyun‐Woong Cho, Kyung‐Jin Min, Sang‐Hoon Kwon, et al.
Journal of Gynecologic Oncology (2021) Vol. 32, Iss. 6
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top